Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-02-15FDA Approved: QUINAPRIL — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Quinapril submitted by BluePoint Laboratories.
-
CLINICAL_TRIALS trial_result · 2008-02-15Clinical Trial Update: SPHERE Hypertension Baseline Data Study
The SPHERE Hypertension Baseline Data Study, sponsored by the University of Washington, has completed and is reporting baseline data for hyp…
-
CLINICAL_TRIALS research · 2008-02-01Clinical Trial Update: Compliance of Antihypertensive Treatment Study (CAT Study)
This record provides a status update on the CAT Study assessing compliance with antihypertensive treatment in hypertension.
-
FDA approval · 2008-01-31FDA Approved: EPLERENONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Eplerenone submitted by Mylan Pharmaceuticals Inc.
-
FDA approval · 2008-01-31FDA Approved: PROPRANOLOL HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a generic version of propranolol hydrochloride for the same indications as the brand product, enabling generic competition for …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-01-29FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for a fixed-dose lisinopril/hydrochlorothiazide product from Actavis, expanding the availability of …
-
CLINICAL_TRIALS trial_result · 2008-01-29Clinical Trial Update: Magnesium and Metabolic Syndrome [Phase 4]
Phase 4 clinical trial evaluating magnesium supplementation in people with diabetes mellitus and hypertension (with hypomagnesemia) has comp…
-
FDA approval · 2008-01-28FDA Approved: LISINOPRIL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for lisinopril from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2008-01-23Clinical Trial Update: Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions [Phase 4]
Phase 4 trial evaluating the effect of irbesartan, ciprofibrate, and their combination on endothelial function in patients with hypertension…
-
CLINICAL_TRIALS trial_result · 2008-01-21Clinical Trial Update: Blood Pressure Reduction in Danish General Practice (BRIDGE) [Phase 4]
This BRIDGE Phase 4 trial update reports on blood pressure reduction in Danish general practice, sponsored by Boehringer Ingelheim.
-
CLINICAL_TRIALS trial_result · 2008-01-21Clinical Trial Update: Adherence to Weight Loss for Hypertension in African American Women [NA]
A completed clinical trial funded by NHLBI examined adherence to weight loss as a strategy for hypertension management in African American w…
-
FDA approval · 2008-01-08FDA Approved: LOPRESSOR — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for Lopressor (metoprolol tartrate) filed by Validus Pharmaceuticals LLC.
-
FDA approval · 2008-01-07FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for propranolol hydrochloride from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2008-01-02FDA Approved: NISOLDIPINE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for nisoldipine submitted by Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: AMISH : Aprovel for Management of Isolated Systolic Hypertension [Phase 4]
Phase 4 clinical trial evaluated Aprovel (irbesartan) for the management of isolated systolic hypertension. The study sponsored by Sanofi ha…
-
CLINICAL_TRIALS trial_result · 2007-12-19Clinical Trial Update: Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age [Phase 3]
Phase 3 dose-range finding trial of candesartan (Atacand) in children aged 6 to under 17 with hypertension has completed.
-
FDA approval · 2007-12-17FDA Approved: BYSTOLIC — Original Application (Allergan, Inc.)
This FDA original approval documents the approval of BYSTOLIC (nebivolol hydrochloride) by Allergan, Inc. for the treatment of hypertension.
-
CLINICAL_TRIALS trial_result · 2007-12-17Clinical Trial Update: Cognitive/Cerebrovascular Consequences of HTN Treatment [NA]
This clinical trial update indicates a completed study conducted by the University of Pittsburgh, examining the cognitive and cerebrovascula…
-
FDA approval · 2007-12-13FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Bisoprolol fumarate (NorthStar Rx LLC), granting supplemental approval for this generic product.
-
CLINICAL_TRIALS research · 2007-12-12Clinical Trial Update: MARIS Study; Mediterranean Approach to Reduce Insulin-Resistance Study [NA]
The MARIS Study (Mediterranean Approach to Reduce Insulin-Resistance) completed; it investigated strategies to reduce insulin resistance in …
-
CLINICAL_TRIALS trial_result · 2007-12-11Clinical Trial Update: Improving Blood Pressure Management in Patients With Diabetes [Phase 4]
Phase 4 clinical trial update on improving blood pressure management in patients with diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-10Clinical Trial Update: Placebo Effects on Blood Pressure [NA]
This document provides a clinical trial update focusing on placebo effects in hypertension (blood pressure). The status and phase are not sp…
-
CLINICAL_TRIALS trial_result · 2007-12-07Clinical Trial Update: Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension [Phase 3]
Phase 3 clinical trial updates for irbesartan/hydrochlorothiazide and irbesartan in treating mild to moderate hypertension have completed. T…
-
CLINICAL_TRIALS trial_result · 2007-12-07Clinical Trial Update: N-Acetylcysteine and Arginine Administration in Diabetic Patients [Phase 4]
A Phase 4 clinical trial evaluating the combination of N-acetylcysteine and arginine in patients with Type 2 Diabetes Mellitus and Hypertens…
-
CLINICAL_TRIALS trial_result · 2007-12-06Clinical Trial Update: Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine [Phase 4]
Phase 4 clinical trial comparing candesartan versus lercanidipine for hypertension in HIV-infected patients.